Symrise has taken a minority shareholding in Synergio, an Israeli developer of next-generation plant bio-actives for cosmetic products.
Founded in Jerusalem in 2009, Synergio’s core technologies include high-performance, broad-spectrum natural antimicrobials that it distributes worldwide.
The German firm said the acquisition would expand its product protection portfolio with plant-based technologies while a strategic partnership will accelerate development of natural antimicrobial solutions.
“It allows us to offer customers the newest and most innovative sustainable plant-based beauty solutions,” said Dr. Joern Andreas, president of Scent & Care at Symrise.
“The development of broad-spectrum antimicrobial solutions will help our customers to create sustainable personal care products,” he added.
The deal gives Symrise the possibility to acquire a majority stake in Synergio’s share capital in future.
Synergio CEO Dr Rachel Lutz said: “Entering a partnership with Symrise provided a unique opportunity to further develop our biotechnologies for the beauty market. Together, we will use new and advanced technology to create sustainable products that will respond to the needs of customers and global stakeholders while meeting regulatory requirements.”
The parties involved agreed to treat the financial details of the investment as confidential.
